Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

TransEnterix Schedules Second Quarter 2016 Financial and Operating Results Conference Call for August 5, 2016

TransEnterix Schedules Second Quarter 2016 Financial and Operating Results Conference Call for August 5, 2016

TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release second quarter 2016 financial and operating results before the market opens on Friday, August 5, 2016. Todd M. Pope, President and Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 8:30 am Eastern Time the same day. The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial, 888-364-3108 for domestic callers and 719-325-2308 for international callers and reference TransEnterix Call approximately ten minutes prior to the start time. To access the live audio webcast or archived recording, use the following link http://ir.transenterix.com/events.cfm. The replay will be available on the Company’s website.

About TransEnterix

TransEnterix is a medical device company that is pioneering the use of robotics to improve minimally invasive surgery by addressing the clinical and economic challenges associated with current laparoscopic and robotic options. The company is focused on the development and commercialization of the ALF-X® System, a multi-port robotic system that brings the advantages of robotic surgery to patients while enabling surgeons with innovative technology such as haptic feedback and eye tracking camera control. The company is also developing the SurgiBot™ System, a single-port, robotically enhanced laparoscopic surgical platform. The ALF-X has been granted a CE Mark, and is commercially available in Europe, but is not available for sale in the U.S. For more information, visit TransEnterix online at www.transenterix.com.

Investor Contact:
Westwicke
Mark Klausner, 443-213-0501
invest@transenterix.com
or
Media Contact:
TransEnterix, Inc.
Mohan Nathan, 919-765-8400
media@transenterix.com